2019 annual financial data
Inhibikase Therapeutics 2019 Net margin
Direct answer
Net margin was -511.95%.
Operating income was -5.7M USD and net income was -5.75M USD.
Operating cash flow was -338,290 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1.12M USD
- Operating income
- -5.7M USD
- Net income
- -5.75M USD
- Operating cash flow
- -338,290 USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inhibikase Therapeutics financial years